S&P 500   3,310.11 (+1.19%)
DOW   26,659.11 (+0.52%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
S&P 500   3,310.11 (+1.19%)
DOW   26,659.11 (+0.52%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
S&P 500   3,310.11 (+1.19%)
DOW   26,659.11 (+0.52%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
S&P 500   3,310.11 (+1.19%)
DOW   26,659.11 (+0.52%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
Log in
NYSE:MED

Medifast Stock Forecast, Price & News

$150.78
+0.93 (+0.62 %)
(As of 10/29/2020 12:00 AM ET)
Add
Compare
Today's Range
$145.40
Now: $150.78▼
$151.49
50-Day Range
$146.12
MA: $164.27▼
$179.37
52-Week Range
$49.03
Now: $150.78▼
$184.29
Volume155,757 shs
Average Volume266,904 shs
Market Capitalization$1.77 billion
P/E Ratio23.56
Dividend Yield3.02%
Beta1.18
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. It offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life, and Flavors of Home brands. The company markets its products through direct ecommerce platform and franchise weight control center channels. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.
Read More
Medifast logo

Beat the Market (BTM) Rank™

Analyst Opinion: 3.3Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.71 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Miscellaneous food preparations & kindred products
Sub-IndustryPersonal Products
SectorConsumer Staples
Current SymbolNYSE:MED
Previous Symbol
CUSIP58470H10
CIK910329
Webwww.medifast1.com
Phone410-581-8042
Employees550

Debt

Debt-to-Equity RatioN/A
Current Ratio1.79
Quick Ratio1.43

Price-To-Earnings

Trailing P/E Ratio23.56
Forward P/E Ratio16.96
P/E GrowthN/A

Sales & Book Value

Annual Sales$713.67 million
Price / Sales2.49
Cash Flow$6.58 per share
Price / Cash Flow22.92
Book Value$9.03 per share
Price / Book16.70

Profitability

EPS (Most Recent Fiscal Year)$5.96
Net Income$77.92 million
Net Margins10.04%
Return on Equity68.55%
Return on Assets36.74%

Miscellaneous

Outstanding Shares11,765,000
Market Cap$1.77 billion
Next Earnings Date11/2/2020 (Confirmed)
OptionableOptionable
$150.78
+0.93 (+0.62 %)
(As of 10/29/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MED News and Ratings via Email

Sign-up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Medifast (NYSE:MED) Frequently Asked Questions

How has Medifast's stock price been impacted by COVID-19?

Medifast's stock was trading at $70.44 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MED stock has increased by 114.1% and is now trading at $150.78.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Medifast?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Medifast.

When is Medifast's next earnings date?

Medifast is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Medifast.

How can I listen to Medifast's earnings call?

Medifast will be holding an earnings conference call on Monday, November 2nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Medifast's earnings last quarter?

Medifast, Inc. (NYSE:MED) released its quarterly earnings results on Wednesday, August, 5th. The specialty retailer reported $1.96 earnings per share for the quarter, topping the consensus estimate of $1.84 by $0.12. The specialty retailer earned $220 million during the quarter, compared to the consensus estimate of $194.75 million. Medifast had a net margin of 10.04% and a return on equity of 68.55%.
View Medifast's earnings history.

How often does Medifast pay dividends? What is the dividend yield for Medifast?

Medifast declared a quarterly dividend on Thursday, September 10th. Shareholders of record on Tuesday, September 22nd will be paid a dividend of $1.13 per share on Friday, November 6th. This represents a $4.52 dividend on an annualized basis and a yield of 3.00%. The ex-dividend date of this dividend is Monday, September 21st.
View Medifast's dividend history.

What price target have analysts set for MED?

4 brokers have issued 12 month price targets for Medifast's stock. Their forecasts range from $180.00 to $230.00. On average, they expect Medifast's stock price to reach $206.67 in the next twelve months. This suggests a possible upside of 37.1% from the stock's current price.
View analysts' price targets for Medifast.

Who are some of Medifast's key competitors?

Some companies that are related to Medifast include The Estée Lauder Companies (EL), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), Prestige Consumer Healthcare (PBH), USANA Health Sciences (USNA), Inter Parfums (IPAR), Revlon (REV), Nature's Sunshine Products (NATR) and Veru (VERU).
View all competitors.

What other stocks do shareholders of Medifast own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medifast investors own include NVIDIA (NVDA), Alibaba Group (BABA), AbbVie (ABBV), Home Depot (HD), The Boeing (BA), Johnson & Johnson (JNJ), Intel (INTC), Cisco Systems (CSCO), AT&T (T) and Exxon Mobil (XOM).

Who are Medifast's key executives?

Medifast's management team includes the following people:
  • Mr. Daniel R. Chard, CEO & Director (Age 55, Pay $2.04M)
  • Mr. William Baker IV, Exec. VP of Information Technology (Age 48, Pay $582.79k)
  • Mr. Anthony Tyree, Chief Marketing Officer (Age 55, Pay $695.03k)
  • Mr. Nicholas M. Johnson, Pres of Coach & Client Experience (Age 40, Pay $564.54k)
  • Mr. James P. Maloney, Chief Financial Officer (Age 52)
  • Ms. Lauren Walker, Exec. VP of Supply Chain Operations
  • Mr. Stephen K. Johnson, VP of Fin. & Chief Accounting Officer (Age 40)
  • Mr. Jason L. Groves, Exec. VP, Gen. Counsel & Corp. Sec. (Age 49)
  • Ms. Claudia Greninger, Exec. VP of HR (Age 47)

What is Medifast's stock symbol?

Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."

Who are Medifast's major shareholders?

Medifast's stock is owned by a variety of retail and institutional investors. Top institutional investors include Ingalls & Snyder LLC (0.42%), Chickasaw Capital Management LLC (0.26%), Robeco Institutional Asset Management B.V. (0.25%), State of Alaska Department of Revenue (0.09%), Anderson Fisher LLC (0.09%) and Alberta Investment Management Corp (0.08%). Company insiders that own Medifast stock include Carl E Sassano, Constance J Hallquist, Daniel R Chard, Jeffrey J Brown, Michael A Hoer, Michael C Macdonald and Scott Schlackman.
View institutional ownership trends for Medifast.

Which major investors are selling Medifast stock?

MED stock was sold by a variety of institutional investors in the last quarter, including Robeco Institutional Asset Management B.V., First Midwest Bank Trust Division, Anderson Fisher LLC, Ingalls & Snyder LLC, Envestnet Asset Management Inc., Alberta Investment Management Corp, Carroll Financial Associates Inc., and First Citizens Bank & Trust Co.. Company insiders that have sold Medifast company stock in the last year include Michael C Macdonald, and Scott Schlackman.
View insider buying and selling activity for Medifast.

Which major investors are buying Medifast stock?

MED stock was bought by a variety of institutional investors in the last quarter, including Empowered Funds LLC, M&G Investment Management Ltd., Campbell & CO Investment Adviser LLC, Louisiana State Employees Retirement System, Bowling Portfolio Management LLC, Nisa Investment Advisors LLC, Avantax Advisory Services Inc., and Campbell Newman Asset Management Inc.. Company insiders that have bought Medifast stock in the last two years include Daniel R Chard, Jeffrey J Brown, and Michael A Hoer.
View insider buying and selling activity for Medifast.

How do I buy shares of Medifast?

Shares of MED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Medifast's stock price today?

One share of MED stock can currently be purchased for approximately $150.78.

How big of a company is Medifast?

Medifast has a market capitalization of $1.77 billion and generates $713.67 million in revenue each year. The specialty retailer earns $77.92 million in net income (profit) each year or $5.96 on an earnings per share basis. Medifast employs 550 workers across the globe.

What is Medifast's official website?

The official website for Medifast is www.medifast1.com.

How can I contact Medifast?

Medifast's mailing address is 100 International Drive, Baltimore MD, 21202. The specialty retailer can be reached via phone at 410-581-8042 or via email at [email protected]

This page was last updated on 10/29/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.